Erdheim–Chester disease: A systematic review
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dalinka, M. K., Brennan, R. E., & Patchefsky, A. S. (1976) · Skeletal Radiology · doi:10.1007/bf00347730 · Cited by 4,089
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Images in Cardiovascular Medicine
(2012) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2012.05.013 · Cited by 1,519
Haroche, J., Charlotte, F., Arnaud, L., von Deimling, A., Hélias-Rodzewicz, Z., Hervier, B., Cohen-Aubart, F., Launay, D., Lesot, A., Mokhtari, K., et al. (2012) · Blood · doi:10.1182/blood-2012-05-430140 · Cited by 696 · cited 3×
“Recently, major genetic nd molecular advances including the detection of recurent BRAFV600E gain-of-function mutations in biopsies and n peripheral blood of ECD patients [6,16], as well as the ecognition of BRAF aberrations in early myelomonocytic recursors or in hematopoietic stem cells of patients with angerhans cel…”
BackgroundMethodConsensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Diamond, E. L., Dagna, L., Hyman, D. M., Cavalli, G., Janku, F., Estrada-Veras, J., Ferrarini, M., Abdel-Wahab, O., Heaney, M. L., Scheel, P. J., et al. (2014) · Blood · doi:10.1182/blood-2014-03-561381 · Cited by 586 · cited 3×
“linical manifestations of ECD at presentation are protean nd encompass bone pain, diabetes insipidus, neurological nd constitutional symptoms, although retroperitoneal, cutaeous, cardiovascular and pulmonary involvement have also een described [4,5].”
BackgroundHaroche, J., Cohen-Aubart, F., Emile, J.-F., Arnaud, L., Maksud, P., Charlotte, F., Cluzel, P., Drier, A., Hervier, B., Benameur, N., et al. (2013) · Blood · doi:10.1182/blood-2012-07-446286 · Cited by 537
Berres, M.-L., Lim, K. P. H., Peters, T., Price, J., Takizawa, H., Salmon, H., Idoyaga, J., Ruzo, A., Lupo, P. J., Hicks, M. J., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130977 · Cited by 442
Arnaud, L., Hervier, B., Néel, A., Hamidou, M. A., Kahn, J.-E., Wechsler, B., Pérez-Pastor, G., Blomberg, B., Fuzibet, J.-G., Dubourguet, F., et al. (2011) · Blood · doi:10.1182/blood-2010-06-294108 · Cited by 383
Erdheim-Chester Disease: a comprehensive review of the literature
Mazor, R. D., Manevich-Mazor, M., & Shoenfeld, Y. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-137 · Cited by 265 · cited 4×
“nd exophthalmos being alternatively included or not as CNS anifestation by different Authors [3–5,23,28].”
BackgroundInfluentialRecurrent RAS and PIK3CA mutations in Erdheim-Chester disease
Emile, J.-F., Diamond, E. L., Hélias-Rodzewicz, Z., Cohen-Aubart, F., Charlotte, F., Hyman, D. M., Kim, E., Rampal, R., Patel, M., Ganzel, C., et al. (2014) · Blood · doi:10.1182/blood-2014-04-570937 · Cited by 244
Targeting the BRAF V600E Mutation in Multiple Myeloma
Andrulis, M., Lehners, N., Capper, D., Penzel, R., Heining, C., Huellein, J., Zenz, T., von Deimling, A., Schirmacher, P., Ho, A. D., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0014 · Cited by 234
Haroche, J., Arnaud, L., & Amoura, Z. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834d861d · Cited by 204 · cited 6×
“It is a rare disorder accounting for p to 600 cases to date, which primarily affects male patients etween their 5th and 7th decade of life [2].”
BackgroundResultInfluentialCavalli, G., Guglielmi, B., Berti, A., Campochiaro, C., Sabbadini, M. G., & Dagna, L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202542 · Cited by 193 · cited 7×
“nd exophthalmos being alternatively included or not as CNS anifestation by different Authors [3–5,23,28].”
BackgroundInfluentialLachenal, F., Cotton, F., Desmurs-Clavel, H., Haroche, J., Taillia, H., Magy, N., Hamidou, M., Salvatierra, J., Piette, J.-C., Vital-Durand, D., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0160-9 · Cited by 175
Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease
Aouba, A., Georgin-Lavialle, S., Pagnoux, C., Martin Silva, N., Renand, A., Galateau-Salle, F., Le Toquin, S., Bensadoun, H., Larousserie, F., Silvera, S., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279240 · Cited by 143
Haroche, J., Arnaud, L., Aubart, F. C., Hervier, B., Charlotte, F., Emile, J., & Amoura, Z. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-014-0412-0 · Cited by 136
Inflammatory and granulomatous expansive lesions of the pituitary
Carpinteri, R., Patelli, I., Casanueva, F. F., & Giustina, A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.05.009 · Cited by 132
Treatment of Erdheim-Chester Disease with Long-Term High-Dose Interferon-α
Hervier, B., Arnaud, L., Charlotte, F., Wechsler, B., Piette, J. C., Amoura, Z., & Haroche, J. (2012) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.11.004 · Cited by 114
Cangi, M. G., Biavasco, R., Cavalli, G., Grassini, G., Dal-Cin, E., Campochiaro, C., Guglielmi, B., Berti, A., Lampasona, V., von Deimling, A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204924 · Cited by 112
Kriegl, L., Neumann, J., Vieth, M., Greten, F. R., Reu, S., Jung, A., & Kirchner, T. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.43 · Cited by 99
Erdheim-Chester Disease: Characteristics and Management
Munoz, J. L., Jankú, F., Cohen, P. R., & Kurzrock, R. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.01.023 · Cited by 95 · cited 2×
“[8] Munoz J, Janku F, Cohen PR, Kurzrock R.”
BackgroundDagna, L., Corti, A., Langheim, S., Guglielmi, B., COBELLI, F. D., Doglioni, C., Fragasso, G., Sabbadini, M. G., & Ferrarini, M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.9911 · Cited by 86
Detection of an NRAS mutation in Erdheim-Chester disease
Diamond, E. L., Abdel-Wahab, O. I., Pentsova, E. I., Borsu, L. A., Chiu, A., Teruya‐Feldstein, J., Hyman, D. M., & Rosenblum, M. K. (2013) · Blood · doi:10.1182/blood-2013-02-482984 · Cited by 66
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease
Jankú, F., Vibat, C. R. T., Kosco, K. A., Holley, V. R., Cabrilo, G., Meric‐Bernstam, F., Stepanek, V. M. T., Lin, P. P., Leppin, L., Hassaine, L., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1964 · Cited by 62
New Insights Into the Molecular Pathogenesis of Langerhans Cell Histiocytosis
Rizzo, F. M., Cives, M., Simone, V. D., & Silvestris, F. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0341 · Cited by 55 · cited 2×
“[7] Rizzo FM, Cives M, Simone V, Silvestris F.”
BackgroundSelf-citationSurgical biopsies in patients with central diabetes insipidus and thickened pituitary stalks
Jian, F., Bian, L., Sun, S., Yang, J., Chen, X., Chen, Y., Ma, Q., Miao, F., Wang, W., Ning, G., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0184-3 · Cited by 55
Mayadev, J., Douglas, J. G., Storer, B. E., Appelbaum, F. R., & Storb, R. F. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.01.062 · Cited by 44
KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas
Rahman, M. T., Nakayama, K., Rahman, M., Katagiri, H., Katagiri, A., Ishibashi, T., Ishikawa, M., Sato, E., Iida, K., Nakayama, N., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140713748 · Cited by 38
Creutzig, U., Zimmermann, M., Bourquin, J., Dworzak, M. N., Fleischhack, G., von Neuhoff, C., Sander, A., Schrauder, A., von Stackelberg, A., Ritter, J., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22955 · Cited by 34
BRAF and MEK Gene Rearrangements in Melanoma: Implications for Targeted Therapy
Madureira, P., & de Mello, R. A. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0081-0 · Cited by 10
A 72‐Year‐Old Man With Dyspnea, Circumferential Aortic Thickening, and Weight Loss
Arcos, I. L., Santos‐Ortega, A., Rodríguez-Palomares, J. F., Juanós-Iborra, M., Buján-Rivas, S., Tornos, P., & Martínez‐Valle, F. (2013) · Arthritis Care & Research · doi:10.1002/acr.22100 · Cited by 4
Cited by
Seltene Erkrankungen der Orbita
Kisser, U., Heichel, J., & Glien, A. (2021) · Laryngo-Rhino-Otologie · doi:10.1055/a-1384-4641 · Cited by 20
Metadata
- Authors
- Cives, M., Simone, V., Rizzo, F. M., Dicuonzo, F., Cristallo Lacalamita, M., Ingravallo, G., Silvestris, F., & Dammacco, F.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 95
- Issue
- 1
- Pages
- 1-11
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W1990211334
- Cited by
- 199
- References
- 32
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.